NWAM LLC’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Sell
14,360
-13,189
-48% -$160K 0.01% 670
2026
Q1
$385K Sell
27,549
-1,500
-5% -$21K 0.02% 457
2025
Q4
$411K Buy
+29,049
New +$437K 0.02% 429
2024
Q1
Sell
-10,060
Closed -$171K 565
2023
Q4
$171K Buy
+10,060
New +$200K 0.01% 537

Other funds holding BTAL

NWAM LLC's BTAL Position: Q2 2026 in Review

NWAM LLC reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 48% in Q2 2026, selling an estimated $160K and leaving 14,360 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #670.

NWAM LLC first reported a position in BTAL in Q4 2023 and has held it in 4 quarters since. The position peaked at $411K in Q4 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • NWAM LLC held 14,360 shares of AGF US Market Neutral Anti-Beta Fund worth $160K as of Q2 2026.
  • NWAM LLC sold 13,189 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $160K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.01% of NWAM LLC's portfolio in Q2 2026, its #670 holding.
  • NWAM LLC first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 4 quarters since.
  • NWAM LLC's AGF US Market Neutral Anti-Beta Fund position peaked at $411K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.